Cargando…

Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States

Background: Endometrial cancer (EC) represents a substantial economic burden for patients in the United States. Patients with advanced or recurrent EC have a much poorer prognosis than patients with early-stage EC. Data on healthcare resource utilization (HCRU) and costs for patients with advanced o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Monica, Garside, Jamie, Nguyen, Joehl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637624/ https://www.ncbi.nlm.nih.gov/pubmed/37954059 http://dx.doi.org/10.36469/001c.88419

Ejemplares similares

Treatment Patterns and Outcomes Among Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
por: Coleman, Robert L., et al.
Publicado: (2023)

Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant
por: Kale, Hrishikesh P., et al.
Publicado: (2021)

Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
por: Fu, Alex Z., et al.
Publicado: (2022)

Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
por: Elsaid, Mohamed I., et al.
Publicado: (2020)

Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA
por: Estes, Stephanie J., et al.
Publicado: (2020)

A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients
por: Li, Gang, et al.
Publicado: (2020)

Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013
por: McPherson, Timothy, et al.
Publicado: (2016)

Healthcare Costs of Clostridioides difficile Infection in Commercially Insured Younger Adults
por: Sahrmann, John M, et al.
Publicado: (2023)

Utilization and Costs of Gender-Affirming Care in a Commercially Insured Transgender Population
por: Baker, Kellan, et al.
Publicado: (2022)

Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States
por: Kabadi, Shaum M., et al.
Publicado: (2019)

The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States
por: Estes, Stephanie J, et al.
Publicado: (2020)

Analyzing the use and impact of elexacaftor/tezacaftor/ivacaftor on total cost of care and other health care resource utilization in a commercially insured population
por: Smith, Spenser, et al.
Publicado: (2022)

1019. Healthcare Resource Utilization and Cost of People Living with HIV (PLWH) in US Commercial and Medicare Advantage Health Plans
por: Priest, Julie, et al.
Publicado: (2020)

Multiple Comorbidities, Psychiatric Disorders, Healthcare Resource Utilization and Costs Among Adults with Essential Tremor: A Retrospective Observational Study in a Large US Commercially Insured and Medicare Advantage Population
por: Dai, Dingwei, et al.
Publicado: (2022)

An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial Cancer
por: Mathews, Cara, et al.
Publicado: (2022)

Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA
por: Olson, Amy L., et al.
Publicado: (2020)

Increased Healthcare Resource Use and Costs After Discontinuation of Liraglutide in Patients with Type 2 Diabetes from a Commercial- and Medicaid-Insured Claims Database
por: Uzoigwe, Chioma, et al.
Publicado: (2022)

Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States
por: Zhang, Dongmu, et al.
Publicado: (2018)

Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain
por: Tafalla, Monica, et al.
Publicado: (2010)

Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States
por: St. Peter, Wendy L., et al.
Publicado: (2018)

Real-world treatment modalities, health care resource utilization, and costs among commercially insured patients with newly diagnosed major depressive disorder in the United States
por: Pizzicato, Lia N, et al.
Publicado: (2023)

Healthcare utilization and costs for patients initiating Dabigatran or Warfarin
por: Reynolds, Shannon L., et al.
Publicado: (2017)

Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs
por: Surrey, Eric, et al.
Publicado: (2020)

Healthcare resource utilization and costs associated with anogenital warts in Morocco
por: Berrada, Myriam, et al.
Publicado: (2021)

Impact of discontinuity in health insurance on resource utilization
por: Banerjee, Ritesh, et al.
Publicado: (2010)

Healthcare use in commercially insured youth with mental health disorders
por: Hugunin, Julie, et al.
Publicado: (2022)

Alcohol-Attributable Medical Costs in Commercially Insured and Medicaid Populations
por: Ozluk, Pelin, et al.
Publicado: (2022)

Analysis of Healthcare Resource Utilization and Costs after the Initiation of Biologic Treatment in Patients with Ulcerative Colitis and Crohn’s Disease
por: Perera, Sue, et al.
Publicado: (2018)

Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USA
por: Chu, David S, et al.
Publicado: (2013)

Health Care Resource Utilization in Commercially Insured Patients Undergoing Anterior Cervical Discectomy and Fusion for Degenerative Cervical Pathology
por: Marrache, Majd, et al.
Publicado: (2020)

Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019
por: Howe, Sarah J., et al.
Publicado: (2022)

Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US
por: Miloh, Tamir, et al.
Publicado: (2023)

Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis
por: Vanderpoel, Julie, et al.
Publicado: (2023)

Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US
por: Shafer, Paul R., et al.
Publicado: (2022)

Healthcare Resource Utilization and Cost of Invasive Meningococcal Disease in Ontario, Canada
por: Rampakakis, Emmanouil, et al.
Publicado: (2019)

Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia
por: Balkhi, Bander, et al.
Publicado: (2023)

Impact of Medication Adherence on Healthcare Resource Utilization, Work Loss, and Associated Costs in a Privately Insured Employed Population Treated With Adalimumab in the United States
por: Mittal, Manish, et al.
Publicado: (2021)

Correction: Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019
por: Howe, Sarah J., et al.
Publicado: (2022)

Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study
por: Marfo, Kwaku, et al.
Publicado: (2023)

The impact of the baby friendly hospital initiative on healthcare utilization among newborns insured by Medicaid in Delaware
por: Harrison-Long, Cecelia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_upuemaknhqpctib7tsgf4hnfjr